Abstract
Extracorporeal membrane oxygenation (ECMO) is intended to provide temporary extracorporeal respiratory support by the use of an artificial membrane lung in case of pulmonary failure unresponsive to conventional treatments. ECMO is indicated in case of high mortality risk, provided the underlying pathology is potentially reversible. In this chapter, we discuss the effects of venovenous ECMO on renal function in adult patients, focusing on the incidence and pathophysiology of renal failure in ECMO patients. Furthermore, we briefly describe the techniques available for combined ECMO and renal replacement therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
